CCL2 and infectious otitis media: Administration of the anti-AQP3 mAb before AOM injection reduced acute liver injury, as shown by reduced AST/ALT and oxidative stress, with reduced TNF-α, CCL2, and α-SMA (Supplementary Fig. 9e–g).